Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
-
New combo therapy aims to boost immune attack on tough lung cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug called PBF-1129 combined with the immunotherapy nivolumab in people with advanced non-small cell lung cancer that has returned or spread. The main goal is to find the safest dose and understand side effects. About 30 adults who have al…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New combo therapy aims to boost immune attack on lung cancer
Disease control Recruiting nowThis early-phase trial tests the safety and best dose of combining two drugs—vismodegib and atezolizumab—in people with advanced non-small cell lung cancer that has returned or spread. Vismodegib blocks certain enzymes that help cancer grow, while atezolizumab helps the immune sy…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy aims to extend life in tough lung cancer
Disease control Recruiting nowThis study tests a combination of chemotherapy (temozolomide) and immunotherapy (atezolizumab) as a second or third treatment option for people with small cell lung cancer that has spread or returned. The goal is to see if this combination can shrink tumors and help patients live…
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated May 19, 2026 11:47 UTC